Suppr超能文献

全视网膜光凝术中疼痛与持续时间的比较分析:Navilas激光与传统激光治疗增殖性糖尿病视网膜病变的对比

Comparative Analysis of Pain and Duration in Panretinal Photocoagulation: Navilas Laser versus Conventional Laser in Proliferative Diabetic Retinopathy.

作者信息

Karapapak Murat, Ozal Ece, Ermis Serhat, Guler Serkan, Altan Ozal Sadik

机构信息

Department of Ophthalmology, University of Health Sciences Türkiye, Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye.

出版信息

Sisli Etfal Hastan Tip Bul. 2024 Sep 30;58(3):325-331. doi: 10.14744/SEMB.2024.81236. eCollection 2024.

Abstract

OBJECTIVES

To compare the pain perception and treatment duration in patients undergoing panretinal photocoagulation (PRP) for high-risk proliferative diabetic retinopathy (PDR) using Navilas laser versus conventional laser.

METHODS

A study was conducted involving 40 patients with bilateral high-risk PDR. Each patient underwent PRP with conventional laser in one eye and Navilas laser in the other. Laser parameters, including spot size and pulse duration were standardized. Pain perception was evaluated using Verbal Rating Scale (VRS) and Visual Analogue Scale (VAS).

RESULTS

The Navilas and conventional laser groups showed no significant differences in baseline visual acuity, lens status, intraocular pressure, cup-to-disc ratio, or cystoid macular edema. The duration of laser treatment was significantly shorter with Navilas laser group (517.3±48.78 seconds, p<0.001). Pain scores (VAS and VRS) were significantly lower in the Navilas laser group (p<0.001, p=0.002 respectively) than in conventional laser group. There was no correlation between VAS and VRS scores and laser time in both the Navilas and conventional laser groups (p>0.05).

CONCLUSION

Utilizing the Navilas laser for PRP in PDR patients offers advantages over conventional lasers, including reduced pain and expedited procedures. These findings contribute valuable insights for optimizing clinical decisions, potentially enhancing patient compliance and minimizing the risk of visual deterioration in diabetic retinopathy treatment.

摘要

目的

比较使用Navilas激光与传统激光对高危增殖性糖尿病视网膜病变(PDR)患者进行全视网膜光凝(PRP)时的疼痛感知和治疗持续时间。

方法

对40例双侧高危PDR患者进行了一项研究。每位患者一只眼睛接受传统激光的PRP治疗,另一只眼睛接受Navilas激光治疗。包括光斑大小和脉冲持续时间在内的激光参数进行了标准化。使用言语评定量表(VRS)和视觉模拟量表(VAS)评估疼痛感知。

结果

Navilas激光组和传统激光组在基线视力、晶状体状态、眼压、杯盘比或黄斑囊样水肿方面无显著差异。Navilas激光组的激光治疗持续时间明显更短(517.3±48.78秒,p<0.001)。Navilas激光组的疼痛评分(VAS和VRS)显著低于传统激光组(分别为p<0.001,p=0.002)。Navilas激光组和传统激光组的VAS和VRS评分与激光治疗时间之间均无相关性(p>0.05)。

结论

在PDR患者中使用Navilas激光进行PRP比传统激光具有优势,包括减轻疼痛和加快治疗过程。这些发现为优化临床决策提供了有价值的见解,可能提高患者的依从性,并在糖尿病视网膜病变治疗中降低视力恶化的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da4e/11472189/acefcb976189/SEMB-58-325-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验